Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare

Scottsdale, AZ – August 20th, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of its Vice President of Scientific Affairs, Dr. Robin A. Robinson, a respected authority on the development of breakthrough biomedical technologies.

RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues

Scottsdale, AZ – August 14, 2019 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the Company’s novel medical device to now spray all varieties of tissues and cells, thus opening the door for its potential application in the regeneration of tissues and organs, beyond skin.

RenovaCare Chairman Invests $15.5 Million to Fund SkinGun Regulatory Submissions and Clinical Trials

Scottsdale, AZ– November 29th, 2018 – RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com) today announced an equity financing for $15.5 million from Kalen Capital Corporation, the family office of Mr. Harmel S. Rayat, majority shareholder and Chairman of RenovaCare. This increases his family office’s total equity investment in RenovaCare since 2013 to over $20 million.